Research Article
Hyperuricemia: An Early Marker for Severity of Illness in Sepsis
Table 1
Baseline characteristics.
| Characteristics | Overall (%) | Uric acid | value | High (%) | Low (%) |
| Age | | | | 0.8519 | <30 years old | 10 (6.9%) | 3 (5.6%) | 7 (7.8%) | | 30–65 years old | 77 (53.5%) | 30 (55.6%) | 47 (52.2%) | | ≥65 years old | 57 (39.6%) | 21 (38.9%) | 36 (40.0%) | | Sex | | | | 0.9653 | Females | 61 (42.4%) | 23 (42.6%) | 38 (42.2%) | | Males | 83 (57.6%) | 31 (57.4%) | 52 (57.8%) | | Ethnicity | | | | 0.2436 | Caucasian | 140 (97.2%) | 51 (94.4%) | 89 (98.9%) | | Black | 3 (2.1%) | 2 (3.7%) | 1 (1.1%) | | BMI | | | | 0.0195 | 18.5–24.9 | 37 (27.2%) | 12 (22.6%) | 25 (30.1%) | | 25–29.9 | 34 (25.0%) | 8 (15.1%) | 26 (31.3%) | | ≥30 | 65 (47.8%) | 33 (62.3%) | 32 (38.6%) | | Comorbidities | | | | | DM | 53 (36.8%) | 22 (40.7%) | 31 (34.4%) | 0.4482 | CAD | 37 (25.7%) | 15 (27.8%) | 22 (24.4%) | 0.6576 | Severe pulmonary disease | 23 (16.0%) | 7 (13.0%) | 16 (17.8%) | 0.4452 | CHF | 14 (9.7%) | 8 (14.8%) | 6 (6.7%) | 0.1101 | CVA | 24 (16.7%) | 7 (13.0%) | 17 (19.9%) | 0.3556 | h/o malignancy | 23 (16.0%) | 10 (18.5%) | 13 (14.4%) | 0.5182 |
|
|
Chi square test.
|